Search

Search Constraints

You searched for: Author/Creator Pinato, David

Search Results

1. 32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study. (9th November 2020)

2. 32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study. (9th November 2020)

3. Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease: 775. (October 2019)

4. Immunotherapy-related adverse events (irAEs) in real world patients with advanced non-small cell lung cancer (aNSCLC) on chemoimmunotherapy: a Spinnaker study sub-analysis. (April 2023)

5. S720 Endoscopic Severity Score of Immune-Mediated Colitis Is More Effective in Guiding Medical Treatment Than Clinical Severity Grade. (October 2022)